US EditionSeptember 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO - Novo Nordisk (NYSE:NVO)
- Berger Montague PC is investigating claims against Novo Nordisk A/S related to federal securities laws.
- Investors who acquired Novo securities between May 7, 2025, and July 28, 2025, may request to be lead plaintiffs by September 30, 2025.
- Novo Nordisk A/S lowered its sales and profit guidance for the second half of 2025, leading to a stock price drop of over 21% on July 29, 2025.
- The stock price fell from $69.00 to $53.94 per share, reflecting a one-day decline of more than 21%.
55 Articles
55 Articles
September 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO - Novo Nordisk (NYSE:NVO)
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE:NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/novo-nordisk-a-s-loss-s…
Bennington Banner
ATTENTION NYSE: NVO INVESTORS: Contact Berger Montague About a Novo Nordisk A/S Class Action Lawsuit
PHILADELPHIA, Aug. 12, 2025 /PRNewswire/ -- Berger Montague PC is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global pharmaceutical company, headquartered in Denmark, after a class action lawsuit was…
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
